Why Is CHEMOURS CO (CC) Stock Moving Today?

Why CC stock is down today

Chemours Co (CC) fell 5.08% to $14.95 in early trading on August 10, 2026, driven by two downgrades from major banks and a lowered price target. The stock opened with a modest gap down and continued to fall throughout the session amid renewed concerns over the company's refrigerant business and profitability.

What Happened

UBS downgraded Chemours from Buy to Neutral, citing refrigerant concerns. Shortly after, Morgan Stanley cut its price target for Chemours from $21 to $18. These moves came alongside the company's announcement of new refrigerants, Opteon ZE and Opteon 515B, which are intended for use in chillers for data centers and other mission-critical environments. While the product launch highlights the company's focus on sustainable cooling solutions, the simultaneous downgrades weighed on investor sentiment. The stock opened at $15.63 and fell to a session low of $14.88 before recovering slightly to close the session at $14.96.

What The Data Shows

Chemours is currently unprofitable, with an EPS of -2.03 over the trailing twelve months. The company's revenue has declined by 0.9% year to date, and its net margin remains negative at -5.2%. The stock has a beta of 1.43, indicating higher volatility than the broader market. The intraday session showed weak performance, with volume at 0.2 million shares, or 0.1 times the 3-month average. The stock is currently trading within its 52-week range of $10.44 to $28.67, and offers a dividend yield of 2.32%.

What To Watch

Chemours does not have scheduled earnings in the immediate future. Investors should monitor the breadth of analyst coverage and any further price target adjustments from major firms.